Ming Kuang

1.0k citations
19 papers · 220 indexed · h-index 10
Topics
interferon and immune responses (8 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers)Immune Cell Function and Interaction (2 papers)

In The Last Decade

Ming Kuang

17 papers receiving 218 citations

Peers

Ming Kuang
Comparison fields: 5 of 73
  • Immunology 120
  • Molecular Biology 72
  • Infectious Diseases 50
  • Epidemiology 33
  • Oncology 30
Replace Vera Wimmenauer with:
Vera Wimmenauer Germany
Michelle Sue Jann Lee Japan
Ming-Hsiang Hong Taiwan
Sarah Pollak United States
Luciana Polaco Covre Brazil
Xuemei Feng China
Shucheng Hua China
Alexandra Svensson Sweden
David I. Weiss United States
Denis Gaucher Canada
Ming Kuang relative to Vera Wimmenauer Germany Vera Wimmenauer's profile →
Citations per field
00.5×4.5×
Vera Wimmenauer · 1×
Citations per year

Countries citing papers authored by Ming Kuang

Since Specialization
Citations

This map shows the geographic impact of Ming Kuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Kuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Kuang more than expected).

Fields of papers citing papers by Ming Kuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Kuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Kuang. The network helps show where Ming Kuang may publish in the future.

Co-authorship network of co-authors of Ming Kuang

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Kuang. A scholar is included among the top collaborators of Ming Kuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Kuang. Ming Kuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 0
2 0
3 14
4 5
5 29
6 32
7 2
8 21
9 11
10 11
11 8
12 1
13 25
14 5
15 1
16 4
17 18
18 16
19
Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma.
17

About Ming Kuang

Ming Kuang is a scholar working on Immunology, Family Practice and Hepatology, having authored 19 papers that have together received 220 indexed citations. Recurring topics across this work include interferon and immune responses (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Immunology (120 citations), Infectious Diseases (50 citations) and Hepatology (10 citations). Ming Kuang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Fuping You, Xueqin Liu, Yuanan Lu, Luoying Chen, Yunfei Li, Lili Cao, Shengde Liu, Hongqiang Du, Xuefei Guo and Li Lin. Their work appears in journals such as International Journal of Molecular Sciences, Science Advances and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026